Brooklyn Investment Group

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1795705 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$1,459,516

+$513,204 QoQ

Shares Held

1,889

+54.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brooklyn Investment Group holds $23,138,608 across 42 Biotechnology names. REGN ranks #2 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,245	$2,788,642
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,889	$1,459,516
3	ROIV	Roivant Sciences Ltd.	50,312	$1,393,642
4	ARGX	Argenx SE	1,697	$1,239,234
5	MRNA	Moderna, Inc.	23,110	$1,173,988
6	GMAB	Genmab A/S	35,823	$961,131
7	ASND	Ascendis Pharma A/S	4,072	$931,388
8	RVMD	Revolution Medicines, Inc.	8,994	$874,666

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,459,516	1,889	+54.1%	Shares	Defined	2026-04-29
2025-12-31	$946,312	1,226	+194.7%	Shares	Defined	2026-02-12
2025-09-30	$233,904	416	+2.2%	Shares	Defined	2025-11-14
2025-06-30	$213,675	407	-20.2%	Shares	Defined	2025-08-14
2025-03-31	$323,457	510	+29.4%	Shares	Defined	2025-05-13
2024-12-31	$280,658	394	-24.2%	Shares	Defined	2025-01-15
2024-09-30	$546,644	520	+7.4%	Shares	Defined	2024-11-13
2024-06-30	$508,698	484	0.0%	Shares	Defined	2024-08-12
2024-03-31	$465,845	484	-2.8%	Shares	Defined	2024-05-07
2023-12-31	$437,388	498	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.